Next Article in Journal
Prevalence of New-Onset Otological Symptoms in Patients with Temporomandibular Disorders
Previous Article in Journal
Otorhinolaryngological Advancements in Phoniatrics
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Current Opinions in Otorhinolaryngology in Japan

Department of Otorhinolaryngology, Head and Neck Surgery, University of Fukui, Fukui 910-1193, Japan
J. Otorhinolaryngol. Hear. Balance Med. 2022, 3(2), 2;
Original submission received: 6 April 2022 / Revised: 9 April 2022 / Accepted: 12 April 2022 / Published: 15 April 2022
(This article belongs to the Special Issue Current Opinions in Otorhinolaryngology in Japan)
The field of otolaryngology has developed through the continuous efforts of otolaryngologists around the world. Changes that have swept the field over the past decade have been particularly dramatic. In the field of otology, the widespread use of cochlear implants has dramatically improved the quality of life of people with sensorineural hearing loss [1,2]. In the field of rhinology, the role of eosinophils in sinusitis is being explored continuously [3,4]. Antibody applications have been developed to alleviate and mitigate symptoms dramatically. In pharyngo-laryngology, improvements in surgical procedures have progressed to improve speech and swallowing functions [5,6]. For treating head and neck cancers, new options such as EGFR antibody drugs and cancer immunotherapy are transforming treatment strategies [7]. These remarkable advances have stimulated considerable improvement of prognoses and patients’ quality of life. This Special Issue presents, from various perspectives, recent findings achieved in the field of otorhinolaryngology in Japan.
We encouraged Japanese otolaryngologists to submit review articles, clinical studies, translational research, basic research, and even case reports that can be expected to lead to breakthroughs and to deepen our understanding of the following areas:
  • Otology, hearing, neuro-otology (e.g., cochlear implant, middle ear surgery, hereditary hearing loss, equilibrium medicine);
  • Rhinology (e.g., rhinosinusitis, allergic rhinitis, and benign/malignant tumors);
  • Pharynx and larynx (e.g., swallowing/phonation, and transoral surgery with and without robots);
  • Head and neck surgery for malignant or benign tumors (e.g., treatment strategies with radiation and chemotherapeutical agents, operation, and cancer immunotherapy).

Conflicts of Interest

The author declares no conflict of interest.


  1. Giallini, I.; Nicastri, M.; Mariani, L.; Turchetta, R.; Ruoppolo, G.; de Vincentiis, M.; Vito, C.; Sciurti, A.; Baccolini, V.; Mancini, P. Benefits of Parent Training in the Rehabilitation of Deaf or Hard of Hearing Children of Hearing Parents: A Systematic Review. Audiol. Res. 2021, 11, 653–672. [Google Scholar] [CrossRef] [PubMed]
  2. Carlyon, R.P.; Goehring, T. Cochlear Implant Research and Development in the Twenty-first Century: A Critical Update. J. Assoc. Res. Otolaryngol. 2021, 22, 481–508. [Google Scholar] [CrossRef] [PubMed]
  3. Yoshida, K.; Takabayashi, T.; Imoto, Y.; Sakashita, M.; Narita, N.; Fujieda, S. Reduced nasal nitric oxide levels in patients with eosinophilic chronic rhinosinusitis. Allergol. Int. 2019, 68, 225–232. [Google Scholar] [CrossRef] [PubMed]
  4. Imoto, Y.; Takabayashi, T.; Sakashita, M.; Kato, Y.; Yoshida, K.; Kidoguchi, M.; Koyama, K.; Adachi, N.; Kimura, Y.; Ogi, K.; et al. Enhanced 15-Lipoxygenase 1 Production is Related to Periostin Expression and Eosinophil Recruitment in Eosinophilic Chronic Rhinosinusitis. Biomolecules 2020, 10, 1568. [Google Scholar] [CrossRef]
  5. Chang, W.D.; Chen, S.H.; Tsai, M.H.; Tsou, Y.A. Autologous Fat Injection Laryngoplasty for Unilateral Vocal Fold Paralysis. J. Clin. Med. 2021, 10, 5034. [Google Scholar] [CrossRef]
  6. Wu, P.I.; Szczesniak, M.M.; Omari, T.; Lam, T.Y.; Wong, M.; Maclean, J.; Ma, K.K.; Chan, A.Y.; Mok, V.; Cook, I.J.; et al. Cricopharyngeal peroral endoscopic myotomy improves oropharyngeal dysphagia in patients with Parkinson’s disease. Endosc. Int. Open 2021, 9, E1811–E1819. [Google Scholar] [CrossRef] [PubMed]
  7. Porcheri, C.; Mitsiadis, T.A. New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas. Cancers 2021, 13, 5515. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Narita, N. Current Opinions in Otorhinolaryngology in Japan. J. Otorhinolaryngol. Hear. Balance Med. 2022, 3, 2.

AMA Style

Narita N. Current Opinions in Otorhinolaryngology in Japan. Journal of Otorhinolaryngology, Hearing and Balance Medicine. 2022; 3(2):2.

Chicago/Turabian Style

Narita, Norihiko. 2022. "Current Opinions in Otorhinolaryngology in Japan" Journal of Otorhinolaryngology, Hearing and Balance Medicine 3, no. 2: 2.

Article Metrics

Back to TopTop